How to Develop a New Multiplex SARS‑CoV‑2 Variant Neutralizing Antibody Assay in a day

Choose your preferred day and time from the following options:

Americas and European Session

Jun 15
Wed 9:00 PM PDT

Asia Pacific Session

Nov 22
Mon 11:00 AM SGT

In this webinar we will discuss the utilization of Bio‑Plex Pro Human SARS‑CoV‑2 Neutralization Custom Assay Developer Kit to efficiently develop new variant assays for the detection and determination of percentage inhibition of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) neutralizing antibodies with affinity to SARS‑CoV‑2 variants.

You will learn about:​

  • Competitive multiplex immunoassay technology (format) in SARS‑CoV‑2 neutralizing antibody assay development
  • Conjugating a SARS‑CoV‑2 variant antigen to a magnetic bead​
  • Developing a SARS‑CoV‑2 neutralizing antibody assay using Bio‑Plex SARS‑CoV‑2 Neutralization Antibody Custom Assay Developer Kit​
  • Determination of percent inhibition of SARS‑CoV‑2 neutralizing antibodies
Qian Gao

Qian Gao, PhD,
R&D Manager, Bio-Plex Immunoassays

Qian Gao is the R&D Manager of Bio‑Plex Immunoassays at Bio‑Rad Laboratories. He obtained an MA Degree in Immunology at Beijing University, and a Ph.D. in Microbiology at The Fourth Military Medical School, China. He did 4 years of postdoctoral research on virology at Northwestern University, Chicago and Kansas Medical Center, Kansas City. He joined Bio‑Rad Laboratories in 1995 and has worked in both Clinical Diagnostics and Life Science groups on different projects related to disease diagnosis and life science research. He has over twenty years of experience in developing multiplex immunoassays and has been involved in the development of over 600 Bio‑Plex multiplex immunoassays for use in disease research and drug development.

Vanitha Margan

Vanitha Margan,
Global Product Manager, Bio-Plex Immunoassays

Vanitha Margan is the Global Product Manager for the Immunoassays Team at Bio‑Rad Laboratories. She graduated with a Bachelor of Applied Science from Swinburne University of Technology, Australia with a double major in Biochemistry and Chemistry. She earned her MBA from the University of Phoenix, USA. She started her career as a medical laboratory scientist in a clinical laboratory and has held field application specialist and sales roles for a clinical diagnostics and life science products distributor in Malaysia. Since joining Bio‑Rad in 2007, she has held roles in both Clinical Diagnostics and Life Science Groups spanning from technical support, sales, regional marketing, and global commercialization marketing. Her specialties include clinical chemistry, diabetes monitoring, infectious diseases, inflammation markers, and laboratory quality control.

Brett Houser

Brett Houser,
Global Product Manager, Bio‑Plex Immunoassays

Brett Houser is a Global Product Manager at Bio-Rad Laboratories. He received a B.S. in Biochemistry from California Polytechnic State University, San Luis Obispo. Prior to working with the Bio‑Plex product line, Brett managed protein detection consumables for mass spectrometry applications.